GlassScriptPhysician profile
Mounzer Soued
NPI 1780779355
$2,475.17
in general payments reported to CMS, 2019-2025
22 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $230 · 2021: $336 · 2022: $398 · 2023: $482 · 2024: $335 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,174.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $655.27 | 2019-2025 | Skyrizi, Creon, Linzess |
| Janssen Biotech, INC. | $497.65 | 2020-2025 | Stelara, Tremfya |
| Ironwood Pharmaceuticals, INC | $204.65 | 2019-2023 | Linzess |
| Celgene Corporation | $186.27 | 2022-2024 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $135.16 | 2021-2025 | Gattex, Entyvio |
| Pfizer INC. | $88.59 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.71 | 2019-2022 | |
| Boston Scientific Corporation | $79.24 | 2020 | |
| Conmed Corporation | $76.20 | 2025 | Conmed Generators |
| Janssen Scientific Affairs, LLC | $66.19 | 2022 | |
| Phathom Pharmaceuticals, INC. | $54.39 | 2024-2025 | Voquezna |
| Shionogi INC | $52.32 | 2019 | |
| Lilly USA, LLC | $49.91 | 2024-2025 | Omvoh |
| Gilead Sciences, INC. | $44.84 | 2019-2025 | |
| Genzyme Corporation | $41.88 | 2022-2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $35.72 | 2023-2025 | Ibsrela |
| Axonics, INC. | $33.64 | 2023 | Axonics |
| Nestle Healthcare Nutrition INC. | $19.62 | 2022 | |
| Evoke Pharma, INC. | $19.56 | 2024 | |
| Braintree Laboratories, INC. | $17.19 | 2020 | |
| Ferring Pharmaceuticals INC. | $16.81 | 2020 | |
| Olympus America INC. | $15.36 | 2024 | Evis Exera III Colonovideoscope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mounzer Soued listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.